BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3564859)

  • 1. Tumor distribution classification system for multiple myeloma: clinical features and prognosis.
    Sezaki T; Izumi K; Hoshijima T; Adachi T; Takahashi I; Kimura I
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1784-91. PubMed ID: 3564859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T
    Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnosis of multiple myeloma].
    Bartl R; Fateh-Moghadam A
    Onkologie; 1986 Aug; 9(4):183-8, 190-5. PubMed ID: 3531945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
    Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
    Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic classification and staging of multiple myeloma.
    Bartl R
    Hematol Oncol; 1988; 6(2):107-13. PubMed ID: 3391529
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone lesions in multiple myeloma: variation and value of radiologic classification in prognosis].
    Elloumi M; Bellaaj H; Ayedi K; Zitoun I; Mseddi S; Frikha M; Kechaou MS; Souissi T
    Tunis Med; 2002 Sep; 80(9):519-23. PubMed ID: 12632764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.
    Bartl R; Frisch B; Fateh-Moghadam A; Kettner G; Jaeger K; Sommerfeld W
    Am J Clin Pathol; 1987 Mar; 87(3):342-55. PubMed ID: 3825999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic soundness of the cytologic and histologic examination of the bone marrow in myeloma].
    Bettini R; Rapazzini P; Ferrari V; Ambruzzi AM; Mascalzi MG; Steidl L
    Recenti Prog Med; 1986; 77(7-8):357-61. PubMed ID: 3786936
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow imaging in plasma cell dyscrasias: review of 130 cases.
    Feggi LM; Scutellari PN; Prandini N; Orzincolo C; Spanedda R
    J Nucl Biol Med (1991); 1992; 36(4):303-8. PubMed ID: 1296769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic and quantitative MRI assessment of bone marrow in multiple myeloma and chronic lymphocytic leukemia: clinical and prognostic value.
    Lecouvet F
    J Belge Radiol; 1998 Dec; 81(6):301. PubMed ID: 10063768
    [No Abstract]   [Full Text] [Related]  

  • 12. Computed tomography in diagnosis and management of multiple myeloma and its variants.
    Kyle RA; Schreiman JS; McLeod RA; Beabout JW
    Arch Intern Med; 1985 Aug; 145(8):1451-2. PubMed ID: 4026477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemocytological classification, clinical staging and polychemotherapy of multiple myeloma].
    István L; Karl W; Michael H; Günter A; Kelényi G; Várbíró M; Dieter R
    Orv Hetil; 1983 Feb; 124(6):313-9. PubMed ID: 6835675
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
    Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis.
    Van de Berg BC; Lecouvet FE; Michaux L; Labaisse M; Malghem J; Jamart J; Maldague BE; Ferrant A; Michaux JL
    Radiology; 1996 Oct; 201(1):243-6. PubMed ID: 8816551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of nucleo-cytoplasmic maturation asynchrony in multiple myeloma.
    Scudla V; Wiedermann B; Kodousek R; Dusek J; Kamarád V; Indrák K
    Neoplasma; 1986; 33(4):483-92. PubMed ID: 3762809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of the examination of plasma-cell morphology in the study of multiple myeloma].
    Moro MJ; Portero JA; Gascón A; Hernández JM; Ortega F; Jiménez R; Guerras L; Martínez M; Casanova F; Sanz MA
    Sangre (Barc); 1992 Jun; 37(3):175-9. PubMed ID: 1440094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of bone marrow biopsy in the multiple myeloma.
    Bartl R; Burkhardt R; Gierster P; Sandel P; Fateh-Moghadam A
    Bibl Haematol; 1978; 45():81-6. PubMed ID: 747638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.